By using CaMeRe, the corresponding reaction with the PGD involved could also be identified in multiple cancers, such as Bladder Urothelial carcinoma (BLCA) (Figure 8), Breast invasive carcinoma (BRCA) (Figure 9) and Thyroid carcinoma (THCA) (Figure 10). This evidence concerns the gene PGD and bladder transitional cell carcinoma.